Home Newsfeeds Piper Sandler Upgrades Comstock Res to Neutral, Raises Price Target to $17

Piper Sandler Upgrades Comstock Res to Neutral, Raises Price Target to $17

Piper Sandler analyst Kashy Harrison upgrades Comstock Res (NYSE:CRK) from Underweight to Neutral and raises the price target from $16 to $17.

byBenzinga Newsdesk

July 22, 2022

1 minute read

Piper Sandler analyst Kashy Harrison upgrades Comstock Res (NYSE:CRK) from Underweight to Neutral and raises the price target from $16 to $17.

$1000 Invested In Micron Technology 15 Years Ago Would Be Worth This Much Today

By Benzinga Insights

July 15, 5:24 PM

Micron Technology (NASDAQ:MU) has outperformed the market over the past 15 years by 4.37% on an annualized basis producing an average annual return of 10.66%. Currently, Micron Technology has a market capitalization of $67.72 billion.

News

Exelon Says Based On Inflation Reduction Act, Currently Estimates Increase In Cash Taxes Of About $200M Per Year Starting In 2023

By Benzinga Newsdesk

August 17, 9:06 AM

-SEC Filing

EXC

NightHawk Biosciences Announces Planned Name Change To Scorpius Holdings, Reflecting Successful Transition To A Large Molecule Biomanufacturing CDMO; In Connection With The Name Change, The Company’s Ticker Will Change To “SCPX”

By Benzinga Newsdesk

January 8, 9:55 AM

NightHawk Biosciences (NYSE:NHWK, NHWK)), an integrated contract development and manufacturing organization (CDMO), today announced that it is changing the name of the Company to Scorpius Holdings, Inc. ("Scorpius") to

NHWK